Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,230 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06938763RecruitingPhase 1
Safety study of J4 in healthy volunteers
This trial tests a new drug called J4 in healthy adults to see if it is safe and how the body processes it. Healthy volunteers aged 18 to 64 may join to help researchers learn about the drug's effects.
TaipeiAges 18–64 - NCT06938867RecruitingPhase 1/Phase 2
Study of SNIPR001 for resistant gut bacteria before stem cell transplant
This study tests an experimental oral medicine called SNIPR001. It is designed to reduce resistant E. coli bacteria in the gut before your stem cell transplant, possibly lowering the risk of infection.
Duarte, CaliforniaAges 18 years+ - NCT06939088RecruitingPhase 2
Tirzepatide for alcohol reduction in schizophrenia
This trial tests if tirzepatide, a once-weekly injection, can help reduce heavy drinking in people who have both schizophrenia and alcohol use disorder. If you struggle with alcohol and have stable schizophrenia, this study may offer a new treatment option.
Aalborg, DenmarkAges 18–70 - NCT06940011RecruitingPhase 2
Endocalyx for hard-to-treat high blood pressure
This trial tests a new treatment called Endocalyx for people whose high blood pressure doesn't get better with multiple medications. It aims to see if Endocalyx can help lower blood pressure when standard medicines aren't enough.
Amsterdam, North HollandAges 18 years+ - NCT06940622Recruiting
D-mannose to prevent recurrent urinary tract infections in older women
This study tests whether a simple sugar called D-mannose can help prevent repeat urinary tract infections (UTIs) in postmenopausal women. If you have had frequent UTIs, this trial will see if D-mannose is a good option to keep you infection-free.
Dallas, TexasAges 55–85 - NCT06940674RecruitingPhase 3
CBD plus opioid treatment for recovery
This study tests whether adding cannabidiol (CBD) to your usual methadone or buprenorphine treatment helps you recover from opioid use disorder. If you're already in stable treatment with those medications, the trial aims to see if CBD can improve your outcomes.
New York, New YorkAges 18–65 - NCT06941155Recruiting
Game-based app to retrain OCD thoughts: a trial
This study tests a fun, game-like mobile app that helps retrain your brain's automatic reactions to reduce OCD symptoms. You would use the app from home for 4 weeks, and it's designed to be a safe, easy addition to your routine.
IzmirAges 18 years+ - NCT06943404RecruitingPhase 2
BXCL501 after a car crash to help recovery
This study tests a medication called BXCL501 to see if it helps people recover from stress after a motor vehicle crash. You can join if you went to the emergency room within 3 days of the crash and are expected to go home.
Jacksonville, FloridaAges 18–65 - NCT06946017Recruiting
Dairy protein and fiber supplement for gut health
This trial tests if a fermented dairy protein drink with added fiber can improve gut symptoms. It is for active people living in Phoenix who may have mild lactose issues.
Phoenix, ArizonaAges 18–50 - NCT06946641RecruitingPhase 1
Testing QLS12010 safety in healthy adults and people with eczema
This trial tests a new drug, QLS12010, to see if it is safe and how it works in healthy volunteers and in people with moderate to severe atopic dermatitis (eczema). It may offer a new treatment option for those whose eczema has not improved with topical creams.
BeijingAges 18–75 - NCT06947135Recruiting
Testing painkiller injection for heart attack patients
This trial tests if injecting a painkiller near neck nerves can reduce heart damage after a heart attack. It is for patients with a specific type of heart attack who are scheduled for a procedure to open blocked arteries.
Hefei, AnhuiAges 18 years+ - NCT06947967RecruitingPhase 3
Tucidinostat plus CHOP for newly diagnosed PTCL-TFH lymphoma
This trial tests a new drug (tucidinostat) added to standard chemotherapy (CHOP) for people newly diagnosed with a specific type of lymphoma called PTCL-TFH. It aims to see if the combination works better than standard treatment alone.
Guangzhou, GuangdongAges 18–80 - NCT06947941RecruitingPhase 3
Testing karxt for psychosis in alzheimer's disease
This study tests whether a new medicine called KarXT can help with psychosis (hallucinations or delusions) in people with Alzheimer's disease. It aims to reduce troubling symptoms while being safe for older adults.
Gilbert, ArizonaAges 55–90 - NCT06947980RecruitingPhase 2
Study of CM512 for moderate-to-severe atopic dermatitis
This trial tests a new treatment called CM512 for people with moderate-to-severe eczema (atopic dermatitis). It aims to see if the drug can improve skin symptoms like itching and rash.
BeijingAges 18–75 - NCT06948357RecruitingPhase 2
Eye drops for presbyopia in Chinese adults
This trial tests two eye drops, BRIMOCHOL PF and CARBACHOL PF, to see if they improve near vision in people with presbyopia (age-related difficulty seeing up close). The study is for Chinese adults aged 45-75 who have trouble reading even with glasses or contacts.
Wenzhou, ZhejiangAges 45–75 - NCT06948799RecruitingPhase 1
Safety study of STSP-0902 in healthy men
This study tests a new drug called STSP-0902 to see if it is safe in healthy men. It may help men with low sperm count or poor sperm movement, but the main goal is to check for side effects.
Beijing, Beijing MunicipalityAges 18–50 - NCT06949033RecruitingPhase 3
Cadonilimab with chemo for stomach cancer
This trial tests a new combination of immunotherapy (cadonilimab) and chemotherapy before and after surgery for a specific type of advanced stomach or gastroesophageal junction cancer. It aims to see if adding this immunotherapy helps shrink tumors and improve outcomes.
Lanzhou, GansuAges 18–75 - NCT06949826RecruitingPhase 4
Buprenorphine for pain after ankle fracture surgery
This trial tests if buprenorphine, a non-opioid pain medicine, works well for people who have not used opioids before. After ankle fracture surgery, you would get buprenorphine instead of stronger opioids to see if it controls pain just as well with fewer side effects.
St Louis, MissouriAges 18 years+ - NCT06950125Recruiting
JUICE HA for age-related muscle loss
This trial tests a dietary supplement called JUICE HA to see if it helps improve muscle strength and function in older adults with age-related muscle loss (sarcopenia). If you qualify, you'll take the supplement and be monitored for any changes.
TaichungAges 65 years+ - NCT06950385RecruitingPhase 3
Testing eRapa medicine for FAP
This trial tests a new medicine called eRapa for people with Familial Adenomatous Polyposis (FAP), a condition that causes many polyps in the colon and raises the risk of cancer. The goal is to see if eRapa can help reduce polyps and improve outcomes.
Arcadia, CaliforniaAges 18 years+ - NCT06951854RecruitingPhase 2
Testing a new drug for children with autism
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
Seoul, SeoulAges 6–15 - NCT06952413RecruitingPhase 2
Rituximab for chronic fatigue syndrome (ME/CFS) trial
This trial tests if rituximab, a drug that affects the immune system, can help people with ME/CFS. You'll receive the drug in the hospital and be monitored for safety and improvement.
Kodaira, TokyoAges 18–65 - NCT06953440RecruitingPhase 4
Dexamethasone injection for wisdom tooth surgery recovery
This trial tests if injecting dexamethasone (a steroid) into the gum after removing lower wisdom teeth can reduce swelling and difficulty opening your mouth. It may help you recover more comfortably after surgery.
Jeddah, Mecca RegionAges 18–65 - NCT06953583RecruitingPhase 3
Testing omaveloxolone for children and teens with Friedreich's Ataxia
This study tests a drug called omaveloxolone (BIIB141) for children and teens with Friedreich’s Ataxia. It looks at how well the drug works and how safe it is over a longer time.
Los Angeles, CaliforniaAges 2–15
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,230 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.